Like this company from several angles (business model, med-tech, register, etc...) and looking to enter. However I cant find any discussion either on here or by the company in the recent half yearly on a pretty important metric.....why has revenue reduced both from the previous half and from the PcP?
Perhaps to do with sign on or paid development fees, versus true annuity style income making for a lumpy revenue stream. Any thoughts on this appreciated.
Ann: Alcidion Half Year Report and Appendix 4D, page-16
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add ALC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
7.3¢ |
Change
-0.002(2.67%) |
Mkt cap ! $98.00M | |||
| Open | High | Low | Value | Volume |
| 7.6¢ | 7.6¢ | 7.1¢ | $64.81K | 889.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 118915 | 7.1¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 7.3¢ | 135194 | 1 |
View Market Depth
| Last trade - 16.10pm 01/08/2024 (20 minute delay) ? |
| ALC (ASX) Chart |